BioStem Technologies files prospectus for resale of up to 2.2 million shares
BSEM•BioStem Technologies filed a prospectus for the resale of up to 2.2 million shares by selling stockholders, according to an SEC filing.
1. Prospectus filing
BioStem Technologies filed a prospectus for the resale of up to 2.2 million shares by selling stockholders.
